Share on LinkedInShare on LinkedIn

ARTICLE · 16 JUNE 2016

The Introduction Of New Evidence Is Permitted During IPR Proceedings

Yesterday, the Federal Circuit issued an opinion clarifying that the introduction of new evidence is not only permitted, but "is to be expected," in inter partes review proceedings.

United StatesIntellectual Property

Yesterday, the Federal Circuit issued an opinion clarifying that the introduction of new evidence is not only permitted, but "is to be expected," in inter partes review proceedings.  As long as the opposing party is given notice of the evidence and an opportunity to respond to it, the introduction of new evidence is permissible under the Administrative Procedure Act (APA).

As background, the patents challenged in the IPRs on appeal relate to treating Pompe's disease with injections of a human acid α-glucosidase.  The PTAB instituted IPR on various obviousness grounds.  After institution, the patent owner argued that, because of all of the combinations of references described in in vivo experiments, a person of ordinary skill in the art would not find those experiments predictive of results in a human patient.  The patent owner further argued that because the PTAB did not institute review based on any references that included in vivo data, the petitioner should not be

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from